COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 164 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $576,228 | +4.0% | 25,782 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $554,056 | +5.6% | 25,782 | +17.9% | 0.00% | 0.0% |
| Q1 2023 | $524,661 | +67164.2% | 21,870 | -34.9% | 0.00% | -50.0% |
| Q4 2022 | $780 | +44.7% | 33,597 | 0.0% | 0.00% | +33.3% |
| Q3 2022 | $539 | -99.9% | 33,597 | +1.9% | 0.00% | 0.0% |
| Q2 2022 | $584,000 | +117.1% | 32,964 | +149.8% | 0.00% | +200.0% |
| Q1 2022 | $269,000 | -39.8% | 13,195 | -44.9% | 0.00% | -50.0% |
| Q4 2021 | $447,000 | -5.5% | 23,940 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $473,000 | -20.4% | 23,940 | -4.7% | 0.00% | 0.0% |
| Q2 2021 | $594,000 | +102.0% | 25,133 | +102.9% | 0.00% | +100.0% |
| Q1 2021 | $294,000 | +149.2% | 12,388 | +20.4% | 0.00% | 0.0% |
| Q3 2019 | $118,000 | -36.6% | 10,288 | -27.2% | 0.00% | 0.0% |
| Q2 2019 | $186,000 | +31.9% | 14,129 | +52.0% | 0.00% | 0.0% |
| Q1 2019 | $141,000 | – | 9,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 289,803 | $6,477,097 | 3.67% |
| Tamarack Advisers, LP | 185,000 | $4,134,750 | 2.68% |
| Rubric Capital Management LP | 3,175,000 | $70,961,250 | 2.66% |
| Eventide Asset Management | 2,631,334 | $58,810,315 | 1.06% |
| Camber Capital Management LP | 1,050,000 | $23,468 | 0.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 559,480 | $12,504,378 | 0.76% |
| EMERALD ADVISERS, LLC | 690,487 | $15,432,380 | 0.75% |
| Values First Advisors, Inc. | 43,507 | $972,374 | 0.63% |
| AlphaCentric Advisors LLC | 49,500 | $1,106,325 | 0.63% |
| SummerHaven Investment Management, LLC | 33,666 | $752,435 | 0.55% |